変形性関節症治療の市場規模および予測（2020年～2030年）、世界および地域シェア、動向、成長機会分析レポートの対象範囲治療タイプ別（経皮的電気神経刺激（TENS）、作業療法、理学療法、血小板リッチ血漿療法と間質血管分画、プロロセラピー、その他）、適応疾患別（変形性膝関節症、変形性脊椎症、足関節症、手関節症、肩変形性関節症、手変形性関節症、その他）、エンドユーザー（病院・クリニック、専門クリニック、外来手術センター、在宅医療、その他）、地域（北米、欧州、アジア太平洋、中東・アフリカ、南米・中米）

Osteoarthritis Therapy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

変形性関節症治療市場規模は、2022年の173億6,000万米ドルから2030年には306億8,000万米ドルに成長すると予測されており、2022～2030年のCAGRは7.4%を記録すると推定されている。変形性関節症の有病率の上昇と、... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2024年2月2日	US$5,190 シングルユーザライセンスライセンス・価格情報注文方法はこちら	199	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

変形性関節症治療市場規模は、2022年の173億6,000万米ドルから2030年には306億8,000万米ドルに成長すると予測されており、2022～2030年のCAGRは7.4%を記録すると推定されている。変形性関節症の有病率の上昇と、薬への依存を減らす革新的な治療オプションが、変形性関節症治療市場の発展を促進する主な要因である。しかし、製品回収が変形性関節症治療市場の成長を阻害している。さらに、変形性関節症療法を促進する、より効果的な治療オプションは、予測期間中に有利な市場動向として機能します。
成長の促進要因
変形性関節症の有病率の上昇が変形性関節症療法市場の成長を牽引
CDCの報告書によると、OAには世界全体で5億人以上が罹患しており、世界人口の7%を占めています。長期障害の主な原因となっている。変形性関節症は、スポーツ選手や関節に怪我や外傷を負った人に多く見られる。さらに、女性に多く、世界の変形性関節症患者の60％を占めている。
世界保健機関（WHO）の報告によると、変形性関節症は高齢者により多くみられます。また、変形性関節症は誰でも罹患する可能性があるが、40歳以上の成人に最も多く見られる疾患である。また、WHOの報告によると、人口の約73％が55歳以上の高齢者であり、そのうち60％が女性である。米国疾病予防管理センター（CDC）の報告によると、米国では3,250万人以上の成人がOAに罹患している。このように、OAの有病率の上昇に伴い、生物学的療法のような新しい治療法が世界的に注目されている。血小板を豊富に含む血漿（PRP）療法は、有望なOA治療法として登場した一例である。PRPは、身体の自然治癒と組織修復プロセスを触媒することで、組織の回復を促進する。
レポートの区分と範囲
変形性関節症治療市場は、治療タイプ、適応疾患、エンドユーザーに区分される。治療タイプに基づき、市場は経皮的電気神経刺激療法（TENS）、作業療法、理学療法、多血小板血漿（PRP）療法および間質血管分画、プロロセラピー、その他に区分される。市場は疾患適応症別に、変形性膝関節症、変形性脊椎症、変形性足関節症、変形性肩関節症、変形性手関節症、その他に区分される。エンドユーザー別では、市場は病院＆クリニック、専門クリニック、外来手術センター（ASC）、在宅医療、その他に区分される。

治療タイプ別の洞察
治療の種類別に見ると、変形性関節症治療市場は経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿・間質血管分画、プロロセラピー、その他に区分される。理学療法セグメントは、2022年の変形性関節症治療市場において、治療タイプ別セグメントで最大の市場シェアを占めている。その他セグメントは予測期間中、最も速いCAGR 7.5％で成長すると予測されている。2022年の療法タイプ別変形性関節症療法市場では、理学療法分野が最大の市場シェアを占めた。その他のセグメントは予測期間中、最も速いCAGR 7.5％で成長すると予測されている。ヨガなどの物理療法は、変形性膝関節症に罹患した患者の身体機能の改善に役立つ。臨床研究では、理学療法（PT）を受けている変形性膝関節症の患者は、グルココルチコイド注射を受けている患者よりも質調整生存年（QOL）が高いことが明らかになっている。さらに、理学療法はグルココルチコイド注射よりも臨床的に効果的であり、より費用対効果の高い選択肢として認識されている。
変形性関節症治療市場のCAGR（年間平均成長率）が最も高いと推定されるのは、その他の分野である。もう1つの治療法は、変形性関節症に対するリハビリテーション療法である。リハビリテーション・プログラムは、痛みを軽減し、機能性を素早く向上させるように設計されている。リハビリの主な目的は、膝OAの症状を和らげ、進行を遅らせることである。将来的な展望とリハビリテーションには、OAの非薬理学的管理に続いて、生活の質、関節機能、筋力、筋力、機能的パフォーマンスを効果的に改善する運動が含まれる。したがって、リハビリテーションプログラムの修正は、最終的に患者の変形性関節症の痛みを軽減し、予測期間中の変形性関節症治療市場の成長を強化する。
疾患ベースの洞察
変形性膝関節症セグメントは、2022年の変形性関節症治療市場において疾患適応症セグメント別で最大の市場シェアを占めており、同セグメントは予測期間中、最も速いCAGR 7.7％で成長すると予測されている。米国科学アカデミーの報告書によると、変形性膝関節症（KO）は疾病負担全体の80％以上を占め、45歳以上の米国成人の約19％が毎年罹患している。メーカーによる革新的な製品の発売は、変形性膝関節症の負担軽減に役立つ。2021年9月、Contura International Ltd.は、膝OAに伴う痛みを緩和するための、安全で効果的、長時間作用型で低侵襲な治療法に対するアンメット・クリニカル・ニーズを満たす、現行療法に代わる新製品「Arthrosamid」の発売を発表した。したがって、膝OAの有病率の上昇と変形性関節症の痛みを最小限に抑える革新的な製品の発売が、変形性関節症治療市場の成長を牽引している。
エンドユーザーに基づく洞察
2022年の変形性関節症治療市場のエンドユーザーセグメント別市場シェアは、在宅ケアセグメントが最大であった。さらに、病院・診療所セグメントは予測期間中に7.5%という最高のCAGRを記録すると推定されている。関節炎を克服するための第一の治療法は、余分な体重を減らすことである。さらに、温熱療法や寒冷療法は、硬くなった関節に柔軟性を取り戻し、関節痛を軽減するのに役立つ。電気毛布や湿熱パッドの使用は、痛みの軽減に役立つことが証明されている。しかし、氷のパックや凍らせた野菜の袋などの冷たい治療法を患部の関節に適用することで、痛みを和らげることができる。このような治療オプションが利用できることは、変形性関節症を自宅で管理するための成功した治療法であることを証明しており、これがホームケア・セグメントの変形性関節症治療市場の成長を牽引している。
地域別分析：
地域別に見ると、世界の変形性関節症治療市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに区分される。2022年には、北米が世界最大の変形性関節症治療薬市場シェアを占めた。アジア太平洋地域は、2022～2030年に最も高いCAGRを記録すると予想されている。北米市場では、米国が変形性関節症治療市場で最大の市場シェアを占めている。米国疾病予防管理センター（CDC）の報告書で明らかにされた統計によると、変形性関節症（OA）は最も一般的な関節炎であり、米国では3,250万人の成人が罹患している。さらに、Osteoarthritis (OA) Action Allianceの報告書によると、米国におけるOAに関連する経済的負担は全体で年間1,368億米ドルと推定されている。さらに、米国レントゲン光線学会（ARRS）の報告書によると、OAの生涯リスクは50％であり、2040年までに米国内の成人の7,800万人（26％）がOAに罹患すると推定されている。
さらに、OA疼痛に対する非薬物療法を目指すメーカーによる新製品の承認は、変形性関節症治療市場の成長に影響を与える。2021年6月、CyMedica Orthopedics社は、変形性膝関節症の痛みに対する非侵襲的治療法である「Intellihab System」のFDA承認を取得したと発表した。この新製品発売は、衰弱性変形性関節症疾患を伴うOA疼痛を治療するために設計された、治療的かつデジタルベースのエコシステムである。したがって、OA治療における治療薬への依存を減らすことを意図した新しい非薬物療法は、予測期間中の変形性関節症治療市場の成長を促進するだろう。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 PEST Analysis
4.2 Pipeline Analysis
4.2.1 Clinical Trial Pipeline Analysis
5. Osteoarthritis Therapy Market – Key Market Dynamics
5.1 Osteoarthritis Therapy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Osteoarthritis
5.2.2 Innovative Therapy Options Reducing Dependency on Medications
5.3 Market Restraints
5.3.1 Product Recall
5.4 Market Opportunities
5.4.1 Availability of Regenerative Medicine
5.5 Future Trends
5.5.1 More Effective Treatment Options
5.6 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market – Global Market Analysis
6.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2022–2030
6.1.1 Overview
6.1.2 Osteoarthritis Therapy Market Revenue (US$ Million), 2022–2030
7. Osteoarthritis Therapy Market Analysis – by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8. Osteoarthritis Therapy Market Analysis – by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9. Osteoarthritis Therapy Market Analysis – by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10. Osteoarthritis Therapy Market – Geographical Analysis
10.1 Overview North America
10.1.1 North America Osteoarthritis Therapy Market Overview
10.1.2 North America: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Therapy Type
10.1.2.2 North America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Disease Indication
10.1.2.3 North America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by End User
10.1.3 North America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.1.3.1 United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.1.1 Overview
10.1.3.1.2 United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.3.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.3.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
10.1.3.2 Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 Overview
10.1.3.2.2 Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.3.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.3.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
10.1.3.3 Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.3.1 Overview
10.1.3.3.2 Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.3.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.3.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
10.2 Europe
10.2.1 Europe Osteoarthritis Therapy Market Overview
10.2.2 Europe: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Therapy Type
10.2.2.2 Europe: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Disease Indication
10.2.2.3 Europe: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by End User
10.2.3 Europe: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.2.3.1 United Kingdom: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.1.1 Overview
10.2.3.1.2 United Kingdom: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.2 Germany: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Overview
10.2.3.2.2 Germany: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.3 France: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.3.1 Overview
10.2.3.3.2 France: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.4 Italy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 Overview
10.2.3.4.2 Italy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.5 Spain: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.5.1 Overview
10.2.3.5.2 Spain: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.6 Rest of Europe: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 Overview
10.2.3.6.2 Rest of Europe: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
10.3 Asia Pacific
10.3.1 Asia Pacific Osteoarthritis Therapy Market Overview
10.3.2 Asia Pacific: Osteoarthritis Therapy Market
10.3.2.1 Asia Pacific: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Therapy Type
10.3.2.2 Asia Pacific: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Disease Indication
10.3.2.3 Asia Pacific: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by End User
10.3.3 Asia Pacific: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.3.3.1 China: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.1.1 Overview
10.3.3.1.2 China: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.2 Japan: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 Overview
10.3.3.2.2 Japan: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.3 India: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.3.1 Overview
10.3.3.3.2 India: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.4 Australia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Overview
10.3.3.4.2 Australia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.5 South Korea: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.5.1 Overview
10.3.3.5.2 South Korea: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.6 Rest of APAC: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 Overview
10.3.3.6.2 Rest of APAC: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.3 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.6.4 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.6.5 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by End User
10.4 Middle East and Africa
10.4.1 Middle East and Africa Osteoarthritis Therapy Market Overview
10.4.2 Middle East and Africa: Osteoarthritis Therapy Market
10.4.2.1 Middle East and Africa: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Therapy Type
10.4.2.2 Middle East and Africa: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Disease Indication
10.4.2.3 Middle East and Africa: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by End User
10.4.3 Middle East and Africa: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.4.3.1 South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.1.1 Overview
10.4.3.1.2 South Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.4.3.2 Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Overview
10.4.3.2.2 Saudi Arabia: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
10.4.3.3 United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.3.1 Overview
10.4.3.3.2 United Arab Emirates: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
10.4.3.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 Overview
10.4.3.4.2 Rest of Middle East and Africa: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.3 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.4.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.4.5 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.5 South and Central America
10.5.1 South and Central America Osteoarthritis Therapy Market Overview
10.5.2 South and Central America: Osteoarthritis Therapy Market
10.5.2.1 South and Central America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Therapy Type
10.5.2.2 South and Central America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Disease Indication
10.5.2.3 South and Central America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by End User
10.5.3 South and Central America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.5.3.1 Brazil: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.1.1 Overview
10.5.3.1.2 Brazil: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.5.3.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.5.3.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User
10.5.3.2 Argentina: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Overview
10.5.3.2.2 Argentina: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.5.3.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.5.3.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User
10.5.3.3 Rest of South and Central America: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.3.1 Overview
10.5.3.3.2 Rest of South and Central America: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.3.3 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.5.3.3.4 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.5.3.3.5 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Global Osteoarthritis Therapy Market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 Vision Quest Industries Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Dr PRP USA LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Estar Technologies Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Zimmer Biomet Holdings Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 DePuy Synthes Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bioventus Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Omron Healthcare Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Exactech Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Medi GmbH & Co KG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Zealmax Innovations Pvt Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners

ページTOPに戻る

Table of Contents

Summary

The osteoarthritis therapy market size is projected to grow from US$ 17.36 billion in 2022 to US$ 30.68 billion by 2030; the market is estimated to record a CAGR of 7.4% during 2022–2030. The rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are the key factors propelling the osteoarthritis therapy market development. However, product recall hamper the osteoarthritis therapy market growth. Furthermore, more effective treatment options to fuel osteoarthritis therapy acts as a lucrative market trend during the forecast period.
Growth Drivers:
Rising Prevalence of Osteoarthritis Drives Osteoarthritis Therapy Market Growth
Globally, OA affects more than 500 million people, accounting for 7% of the world's population, according to the CDC report. It represents a major cause of long-term disability. Osteoarthritis is more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases.
According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among the older population. Also, OA can affect anyone, but the condition is most commonly observed in adults aged 40 years and above. Also, the WHO report further reveals that about 73% of the population is older than 55 years and living with OA, among which 60% are female. According to the Centers for Disease Control and Prevention (CDC) report, over 32.5 million adults in the US are affected by OA. Thus, with the rising prevalence of OA and, new therapy options, such as biological therapy, are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising OA treatment. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.
Report Segmentation and Scope:
The osteoarthritis therapy market is segmented into therapy type, disease indication, and end user. Based on therapy type, the market is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy and stromal vascular fraction, prolotherapy, and others. The market is segmented by disease indication into knee osteoarthritis, spine osteoarthritis, foot & ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. In terms of end-users, the market is segmented into hospitals & clinics, specialty clinics, ambulatory surgical centers (ASCs), homecare, and others.

Therapy Type-Based Insights
By therapy type, the osteoarthritis therapy market is segmented as transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma and stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The others segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The other segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. Physical therapies, such as yoga, help improve physical function in patients affected by knee osteoarthritis. The clinical study reveals that the patients suffering from knee osteoarthritis receiving physical therapy (PT) have gained more quality-adjusted life-years than those receiving glucocorticoid injections. Additionally, physical therapy is clinically more effective than glucocorticoid injection; moreover, it is perceived as a more cost-effective option.
The other segment is estimated to register the highest CAGR for the osteoarthritis therapy market. Another therapy is rehabilitation therapy for osteoarthritis. The rehabilitation program is designed to reduce pain and increase functionality quickly. The rehabilitation's main goal is to relieve knee OA symptoms and slow its progression. The future perspective and rehabilitation include nonpharmacological management of OA followed by exercise, which effectively improves the quality of life, joint function, muscle power, strength, and functional performance. Therefore, modifications in rehabilitation programs will ultimately reduce the patients' osteoarthritis pain, bolstering the osteoarthritis therapy market growth during the forecast period.
Disease Based Insights
The knee osteoarthritis segment held the largest market share of the osteoarthritis therapy market by disease indication segment in 2022, and the same segment is anticipated to grow at the fastest CAGR of 7.7% during the forecast period. According to the National Academy of Science report, knee osteoarthritis (KO) accounts for more than 80% of the total disease burden, affecting nearly 19% of American adults aged 45 years and above annually. Launches of innovative products by manufacturers can help reduce the burden of knee osteoarthritis. In September 2021, Contura International Ltd announced a new product launch, "Arthrosamid," an alternative to current therapy that fulfills an unmet clinical need for a safe, effective, long-acting, and minimally invasive treatment for alleviating pain associated with knee OA. Therefore, the rising prevalence of knee OA and innovative product launches to minimize osteoarthritis pain drive the osteoarthritis therapy market growth.
End User-Based Insights
The homecare segment held the largest market share of the osteoarthritis therapy market by end-user segment in 2022. Additionally, the hospitals & clinics segment is estimated to register the highest CAGR of 7.5% during the forecast period. The first and foremost remedy to overcome arthritis is reducing excess body weight. Additionally, hot and cold therapies can bring back flexibility in stiff joints, which can help reduce joint pain. The use of electric blankets or moist heating pads proves helpful in reducing pain. However, cold treatments such as packs of ice or bags of frozen vegetables can be applied to the affected joints, giving relief. Availability of such treatment options proves to be a successful remedy for managing osteoarthritis at home, which drives the osteoarthritis therapy market growth for the homecare segment.
Regional Analysis:
Based on geography, the global osteoarthritis therapy market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest global osteoarthritis therapy market share. Asia Pacific is expected to register the highest CAGR during 2022–2030. In the North American market, the US accounts for the largest market share of the osteoarthritis therapy market. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million adults in the US. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) adults in the country will have OA.
Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain influence the osteoarthritis therapy market growth. In June 2021, CyMedica Orthopedics announced receiving FDA approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain. The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended to reduce dependency on therapeutics in OA treatment would fuel the growth of the osteoarthritis therapy market during the forecast period.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（ambulatory）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（ambulatory）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?